In this condition, the pathogenic microbes outnumber the beneficial microbiota, leading to the destruction of the intestinal barrier and the activation of TNF-α production, resulting in intestinal inflammation and IBD pathogenesis [7]. The gene discussed is TNF; the disease is inflammatory bowel disease.